Table 19bEHR Prototype Model (N = 3235): Frequency Distribution of Patients by Baseline and HbA1c End Point in Total Sample

Baseline HbA1cStatisticFinal HbA1c at end of observation periodTotal
<7.0%7.0%-7.99%≥8.0%
7.0%-7.99%Frequency9923281711491
Row %66.522.011.5
Column %56.662.717.846.1
8.0%-8.99%Frequency331104250685
Row %48.315.236.5
Column %18.919.926.021.2
9.0%-9.99%Frequency15933162354
Row %44.99.345.8
Column %9.16.316.910.9
10.0%-10.99%Frequency11528108251
Row %45.811.243.0
Column %6.65.411.37.8
11.0%-11.99%Frequency581398169
Row %34.37.758.0
Column %3.32.510.25.2
≥12.0%Frequency9717171285
Row %34.06.060.0
Column %5.53.317.88.8
TotalFrequency17525239603235
Row %54.216.229.7100.0

Abbreviations: EHR, electronic health record; HbA1c, hemoglobin A1c.

From: Benchmarking the Comparative Effectiveness of Diabetes Treatments Using Patient-Reported Outcomes and Socio-Demographic Factors

Cover of Benchmarking the Comparative Effectiveness of Diabetes Treatments Using Patient-Reported Outcomes and Socio-Demographic Factors
Benchmarking the Comparative Effectiveness of Diabetes Treatments Using Patient-Reported Outcomes and Socio-Demographic Factors [Internet].
Testa MA, Su M, Turchin A, et al.
Copyright © 2021. Harvard T.H. Chan School of Public Health. All Rights Reserved.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License which permits noncommercial use and distribution provided the original author(s) and source are credited. (See https://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.